Product Information
MOEXIPRIL HCL 7.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.8877 per EA under NDC 00093001701. Its NADAC has been published 635 times since Nov 28, 2013.
Strength
7.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093001701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MOEXIPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076204On Market Since
5/8/2003
Pharmacological Classes
Price Statistics
The NADAC for MOEXIPRIL HCL 7.5 MG TABLET has been published 635 times since Nov 28, 2013, and over the history we have for it it has risen 197.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8877 per EA |
|---|---|
| All-time high | $0.9671 (Apr 15, 2026) |
| All-time low | $0.2985 (Nov 28, 2013) |
| 52-week high | $0.9671 |
| 52-week low | $0.8531 |
| Median price | $0.7553 |
| Average price | $0.7715 |
| Largest weekly change | +76.0% (Dec 18, 2013) |
| Weeks tracked | 635 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MOEXIPRIL HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MOEXIPRIL HCL 7.5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.8877 per EA (NDC 00093001701), effective Jun 24, 2026.
How has the price of MOEXIPRIL HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MOEXIPRIL HCL 7.5 MG TABLET has risen 197.3%. It has been tracked across 635 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOEXIPRIL HCL 7.5 MG TABLET?
Since Nov 28, 2013, the NADAC for MOEXIPRIL HCL 7.5 MG TABLET has ranged from a low of $0.2985 (Nov 28, 2013) to a high of $0.9671 (Apr 15, 2026), with a median of $0.7553 per EA.
Are there cheaper alternatives to MOEXIPRIL HCL 7.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MOEXIPRIL HCL 7.5 MG TABLET, but none are currently priced below it.
Who manufactures MOEXIPRIL HCL 7.5 MG TABLET?
MOEXIPRIL HCL 7.5 MG TABLET (NDC 00093001701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification